GL
Lakefront Biotherapeutics
GLPGF · OTC
$26.24 +0.00% (+$0.00)
Market Cap 1.51B €
P/E Ratio 2.53x
Div. Yield -
ROE 18.89%
Bulios Fair Price
$34.02
29.6% upside
Current Price
$26.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GLPGF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
99 /100
Cheap P/E 2.53x
EV/EBITDA 3.07x
P/S 1.52x
Growth
94 /100
Growing Rev. growth 30.07%
Book val. growth 8.59%
EPS growth N/A
Profitability
70 /100
Strong Gross margin 97.45%
Net margin 60.23%
Op. margin 39.56%
Quality
85 /100
Excellent ROIC 25,402.40%
ROE 18.89%
ROA 17.82%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 32.82x
Int. coverage 17.78x
Stability
8 /100
Unstable Beta 0.11x
Rev. volatility 189.03%
EPS volatility 203.13%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GLPGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry Gosebruch
Employees
452
Headquarters
Mechelen
Upcoming events
12 NOV
Earnings
Upcoming earnings report